Stroke Statistics in Korea: Part I. Epidemiology and Risk Factors: A Report from the Korean Stroke Society and Clinical Research Center for Stroke
暂无分享,去创建一个
Chang Wan Oh | Byung-Chul Lee | Ji Hoe Heo | Hee-Joon Bae | Dong-Wha Kang | S. Kwon | B. Yoon | D. Kang | C. Oh | Byung‐Chul Lee | H. Bae | J. Heo | Jong S. Kim | O. Bang | K. Yu | K. Hong | Keun-Sik Hong | Kyung-Ho Yu | Oh Young Bang | Sun U. Kwon | J. S. Lee | Byung-Woo Yoon | Jin Soo Lee
[1] J. Barendregt,et al. Global burden of disease , 1997, The Lancet.
[2] K. Reynolds,et al. Global burden of hypertension: analysis of worldwide data , 2005, The Lancet.
[3] David Lee Gordon,et al. Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.
[4] Sc Prospective,et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002 .
[5] P. Duncan,et al. Measurement of Motor Recovery After Stroke: Outcome Assessment and Sample Size Requirements , 1992, Stroke.
[6] Thomas Lumley,et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. , 2003, JAMA.
[7] D. Singer,et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.
[8] KjellAsplund,et al. Country Comparisons of Human Stroke Research Since 2001 , 2012 .
[9] W. Cullen,et al. Research confuses me: what is the difference between case-control and cohort studies in quantitative research? , 2013, Irish medical journal.
[10] Differences of Mortality and Dependence Between Stroke Unit and General Ward Care in Acute Ischemic Stroke Patients. , 2009 .
[11] C. Nam,et al. [Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database]. , 2009, Journal of preventive medicine and public health = Yebang Uihakhoe chi.
[12] L. Appel,et al. Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance Corporation Study. , 1999, JAMA.
[13] S. Nikfar,et al. Organization for Economic Cooperation and Development (OECD) , 2014 .
[14] D. Liew,et al. Estimating the lifetime economic burden of stroke according to the age of onset in South Korea: a cost of illness study , 2011, BMC public health.
[15] S. Jee,et al. Smoking and atherosclerotic cardiovascular disease in women with lower levels of serum cholesterol. , 2007, Atherosclerosis.
[16] D. Mozaffarian,et al. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.
[17] K. Yu,et al. Impact of neurological and medical complications on 3‐month outcomes in acute ischaemic stroke , 2008, European journal of neurology.
[18] Kyu-Hong Kim. Predictors of 30-day mortality and 90-day functional recovery after primary intracerebral hemorrhage : hospital based multivariate analysis in 585 patients. , 2009, Journal of Korean Neurosurgical Society.
[19] O. Persson,et al. Country Comparisons of Human Stroke Research Since 2001: A Bibliometric Study , 2012, Stroke.
[20] 大韓民國統計廳,et al. 死亡原因統計年報 : 人口動態申告에 의한 集計 = Annual report on the cause of death statistics : based on vital registration , 1991 .
[21] Jinkwon Kim,et al. Different prognostic value of white blood cell subtypes in patients with acute cerebral infarction. , 2012, Atherosclerosis.
[22] Anthony S. Kim,et al. Global Variation in the Relative Burden of Stroke and Ischemic Heart Disease , 2011, Circulation.
[23] D. Kang,et al. Burden of Ischemic Stroke in Korea: Analysis of Disability-Adjusted Life Years Lost , 2011, Journal of clinical neurology.
[24] Scott E Kasner,et al. Clinical interpretation and use of stroke scales , 2006, The Lancet Neurology.
[25] S Claiborne Johnston,et al. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling , 2009, The Lancet Neurology.
[26] Werner Hacke,et al. Contemporary Outcome Measures in Acute Stroke Research: Choice of Primary Outcome Measure , 2012, Stroke.
[27] R. Holman,et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.
[28] Keun-Hwa Jung,et al. Secular Trends in Ischemic Stroke Characteristics in a Rapidly Developed Country: Results From the Korean Stroke Registry Study (Secular Trends in Korean Stroke) , 2012, Circulation. Cardiovascular quality and outcomes.
[29] P. Amarenco,et al. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention , 2009, The Lancet Neurology.
[30] C. Oh,et al. Current Status of Stroke Management in Korea , 2002 .
[31] R. Collins,et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.